AN2 Therapeutics (ANTX) Return on Assets (2022 - 2026)

AN2 Therapeutics (ANTX) has 5 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

• Return on Assets for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets advanced to 0.0% in Q1 2026 per ANTX's latest filing, from 0.01% in the prior quarter.
• Over five years, Return on Assets peaked at 0.0% in Q2 2022 and troughed at 0.01% in Q3 2024.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
• On a YoY basis, Return on Assets climbed as much as 0 bps in 2023 and fell as far as 0 bps in 2023.
• A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then retreated by 24 bps to 0.0% in 2023, then dropped by 14 bps to 0.01% in 2024, then declined by 1 bps to 0.01% in 2025, then grew by 15 bps to 0.0% in 2026.
• Business Quant data shows ANTX's Return on Assets at 0.0% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.